< Back to search
Filter
1

A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Fairfax VA
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT07538804

Phase1, Phase2, Recruiting
New

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

for
B-cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Fairfax VA, Macon GA, Fort Wayne IN, Indianapolis IN,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07516093

Phase3, Recruiting
New

Evaluating Treatment Strategies for p53 Mutant Oral Cancer and Oral Cancer Precursors

for
Oral Epithelial Dysplasia (OED),
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 18+

Code: NCT07090070

Recruiting
New

A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

for
Phase 1, NK Cell, IL13Ra, EGFRvIII,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07579208

Phase1, Recruiting
New

Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma

for
Diffuse Large B Cell Lymphoma (DLBCL)
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 70+

Code: NCT06594939

Phase2, Recruiting

Interested in new pancreatic cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma

for
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06675123

Phase1, Recruiting
New

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

for
B-cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Nashville TN, Aurora CO, Eugene OR
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07520006

Phase1, Phase2, Recruiting
New

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

for
Non Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma,
Location: Cleveland OH
Sponsor: Paolo Caimi, MD

Sex: All

Age: 18+

Code: NCT07225439

Phase1, Recruiting

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Boston MA, Hawthorne NY, Richmond VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07063745

Phase2, Phase3, Recruiting

Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation

for
Physical Activity, Sleep,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07140770

Recruiting

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

for
Mantle Cell Lymphoma
Location: Toronto, Calgary, Vancouver
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT07341191

Phase2, Recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

for
Waldenström Macroglobulinemia, Lymphoplasmacytic Lymphoma,
Location: Boston MA
Sponsor: Shayna Sarosiek, MD

Sex: All

Age: 18+

Code: NCT06986174

Phase2, Recruiting

DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC

for
Non Small Cell Lung Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 70+

Code: NCT06364917

Phase2, Recruiting

Aromatherapy Inhaler Use for HSCT Distress

for
Cancer Distress, Cancer Coping,
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT05302583

Recruiting

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

for
SCC - Squamous Cell Carcinoma, Radiotracer,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT07217028

Phase1, Recruiting

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

for
Cervical Squamous Cell Carcinoma,
Location: New Haven CT, Hackensack NJ, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT07169734

Phase1, Phase2, Recruiting

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

for
Clinical Stage 0 Cutaneous Melanoma AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03819296

Phase1, Recruiting

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

for
Advanced Unresectable Gastric Adenocarcinoma,
Location: Coral Springs FL, Tamarac FL, Plantation FL, Hialeah FL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07554521

Phase2, Recruiting

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

for
Non Small Cell Lung Cancer
Location: Manahawkin NJ, Fairfax VA, Weston FL, Pittsburgh PA,
Sponsor: Wayshine Biopharm, Inc.

Sex: All

Age: 18+

Code: NCT06868485

Phase2, Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Scarborough ME, Providence RI, Syracuse NY,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase2, Recruiting